Ancient herbs meet modern medicine in moyamoya trial
NCT ID NCT07286110
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a traditional Chinese herbal formula (Qiqi Shengmai) to standard care can improve blood flow in the brains of people with moyamoya disease. About 66 adults aged 18 to 80 will receive either the herbal formula or a placebo for a set period. The goal is to see if the herbs help reduce the risk of stroke and improve brain function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOYAMOYA DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
180 Fenglin Road, Xuhui District, Shanghai 200032,China
Shanghai, Shanghai Municipality, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily pill and a simple physical therapy delay moyamoya strokes?
- Metaverse meets microsurgery: XR platform aims to sharpen brain bypass precision
- French biobank aims to unlock secrets of rare brain vessel diseases
- Your digital twin could help prevent another stroke
- Could a simple MRI and blood test predict moyamoya before it strikes?
- Massive study aims to predict brain surgery success